Journal of International Oncology››2023,Vol. 50››Issue (5): 257-262.doi:10.3760/cma.j.cn371439-20230302-00052
• Original Articles •Previous ArticlesNext Articles
Yang Ya1, Wang Huili2, Liu Yan1, Guo Jinfeng1, Wang Chunxia1, Lyu Min2, Shan Changping2()
Received:
2023-03-02Revised:
2023-04-13Online:
2023-05-08Published:
2023-06-27Contact:
Shan Changping E-mail:scp9933@163.comYang Ya, Wang Huili, Liu Yan, Guo Jinfeng, Wang Chunxia, Lyu Min, Shan Changping. Effects of GCSH gene on proliferation and apoptosis of gastric cancer SNU-1 cells[J]. Journal of International Oncology, 2023, 50(5): 257-262.
[1] | Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. DOI: 10.3322/caac.21660. doi:10.3322/caac.21660 |
[2] | Adamus A, Müller P, Nissen B, et al. GCSH antisense regulation determines breast cancer cells' viability[J]. Sci Rep, 2018, 8(1): 15399. DOI: 10.1038/s41598-018-33677-4. doi:10.1038/s41598-018-33677-4pmid:30337557 |
[3] | Dufresne J, Bowden P, Thavarajah T, et al. The plasma peptides of breast versus ovarian cancer[J]. Clin Proteomics, 2019, 16: 43. DOI: 10.1186/s12014-019-9262-0. doi:10.1186/s12014-019-9262-0 |
[4] | Zhai T, Muhanhali D, Jia X, et al. Identification of gene co-expression modules and hub genes associated with lymph node metastasis of papillary thyroid cancer[J]. Endocrine, 2019, 66(3): 573-584. DOI: 10.1007/s12020-019-02021-9. doi:10.1007/s12020-019-02021-9pmid:31332712 |
[5] | Kałuzińska Ż, Kołat D, Bednarek AK, et al. PLEK2, RRM2, GCSH: a novel WWOX-dependent biomarker triad of glioblastoma at the crossroads of cytoskeleton reorganization and metabolism alterations[J]. Cancers (Basel), 2021, 13(12): 2955. DOI: 10.3390/cancers13122955. doi:10.3390/cancers13122955 |
[6] | Almhanna K, Cubitt CL, Zhang S, et al. MK-2206, an Akt inhibitor, enhances carboplatinum/paclitaxel efficacy in gastric cancer cell lines[J]. Cancer Biol Ther, 2013, 14(10): 932-936. DOI: 10.4161/cbt.25939. doi:10.4161/cbt.25939pmid:23917345 |
[7] | Ajani JA, Javle M, Eng C, et al. Phase Ⅰ study of DFP-11207, a novel oral fluoropyrimidine with reasonable AUC and low Cmaxand improved tolerability, in patients with solid tumors[J]. Invest New Drugs, 2020, 38(6): 1763-1773. DOI: 10.1007/s10637-020-00939-w. doi:10.1007/s10637-020-00939-w |
[8] | Camera S, Deleporte A, Bregni G, et al. MOMENTUM: a phase Ⅰ trial investigating 2 schedules of capecitabine with aflibercept in patients with gastrointestinal and breast cancer[J]. Clin Colorectal Cancer, 2020, 19(4): 311-318.e1. DOI: 10.1016/j.clcc.2020.05.007. doi:10.1016/j.clcc.2020.05.007 |
[9] | Ono S, Kawada K, Dohi O, et al. Linked color imaging focused on neoplasm detection in the upper gastrointestinal tract: a randomized trial[J]. Ann Intern Med, 2021, 174(1): 18-24. DOI: 10.7326/M19-2561. doi:10.7326/M19-2561 |
[10] | Vranić S, Bešlija S, Gatalica Z. Targeting HER2 expression in cancer: new drugs and new indications[J]. Bosn J Basic Med Sci, 2021, 21(1): 1-4. DOI: 10.17305/bjbms.2020.4908. doi:10.17305/bjbms.2020.4908 |
[11] | Davies R, Liu L, Taotao S, et al. CRISPRi enables isoform-specific loss-of-function screens and identification of gastric cancer-specific isoform dependencies[J]. Genome Biol, 2021, 22(1): 47. DOI: 10.1186/s13059-021-02266-6. doi:10.1186/s13059-021-02266-6pmid:33499898 |
[12] | Dong N, Ma X, Shen J, et al. Identification and validation of critical genes with prognostic value in gastric cancer[J]. Front Cell Dev Biol, 2022, 10: 1072062. DOI: 10.3389/fcell.2022.1072062. doi:10.3389/fcell.2022.1072062 |
[13] | Ucaryilmaz Metin C, Ozcan G. Comprehensive bioinformatic analysis reveals a cancer-associated fibroblast gene signature as a poor prognostic factor and potential therapeutic target in gastric cancer[J]. BMC Cancer, 2022, 22(1): 692. DOI: 10.1186/s12885-022-09736-5. doi:10.1186/s12885-022-09736-5pmid:35739492 |
[14] | Shah RH, Northrup H, Hixson JE, et al. Genetic association of the glycine cleavage system genes and myelomeningocele[J]. Birth Defects Res A Clin Mol Teratol, 2016, 106(10): 847-853. DOI: 10.1002/bdra.23552. doi:10.1002/bdra.23552 |
[15] | Yoshikawa A, Nishimura F, Inai A, et al. Mutations of the glycine cleavage system genes possibly affect the negative symptoms of schizophrenia through metabolomic profile changes[J]. Psychiatry Clin Neurosci, 2018, 72(3): 168-179. DOI: 10.1111/pcn.12628. doi:10.1111/pcn.12628 |
[16] | Lin Y, Zheng Z, Sun W, et al. A novel compound heterozygous variant identified in GLDC gene in a Chinese family with non-ketotic hyperglycinemia[J]. BMC Med Genet, 2018, 19(1): 5. DOI: 10.1186/s12881-017-0517-1. doi:10.1186/s12881-017-0517-1pmid:29304759 |
[17] | Hungermann D, Schmidt H, Natrajan R, et al. Influence of whole arm loss of chromosome 16q on gene expression patterns in oestrogen receptor-positive, invasive breast cancer[J]. J Pathol, 2011, 224(4): 517-528. DOI: 10.1002/path.2938. doi:10.1002/path.2938 |
[18] | Huang J, Shi J, Wu P, et al. Identification of a novel cuproptosis-related gene signature and integrative analyses in thyroid cancer[J]. J Clin Med, 2023, 12(5): 2014. DOI: 10.3390/jcm12052014. doi:10.3390/jcm12052014 |
[19] | Kim D, Fiske BP, Birsoy K, et al. SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance[J]. Nature, 2015, 520(7547): 363-367. DOI: 10.1038/nature14363. doi:10.1038/nature14363 |
[20] | Perry CJ, Finch P, Müller-Taubenberger A, et al. A new mechanism for cannabidiol in regulating the one-carbon cycle and methionine levels in Dictyostelium and in mammalian epilepsy models[J]. Br J Pharmacol, 2020, 177(4): 912-928. DOI: 10.1111/bph.14892. doi:10.1111/bph.14892 |
[21] | Vazquez A, Markert EK, Oltvai ZN. Serine biosynthesis with one carbon catabolism and the glycine cleavage system represents a novel pathway for ATP generation[J]. PLoS One, 2011, 6(11): e25881. DOI: 10.1371/journal.pone.0025881. doi:10.1371/journal.pone.0025881 |
[22] | Rahimifard M, Baeeri M, Mousavi T, et al. Combination therapy of cisplatin and resveratrol to induce cellular aging in gastric cancer cells: focusing on oxidative stress, and cell cycle arrest[J]. Front Pharmacol, 2023, 13: 1068863. DOI: 10.3389/fphar.2022.1068863. doi:10.3389/fphar.2022.1068863 |
[1] | Ren Lu, Xie Xiaoli, Zhang Kun, Wang Lijuan.Effects and mechanisms of dihydroartemisinin combined with carfilzomib on the activity, proliferation, and apoptosis of multiple myeloma cells[J]. Journal of International Oncology, 2024, 51(3): 129-136. |
[2] | Zhang Keping, Zhao Yongsheng, Yang Juan, Fu Maoyong.Chlorogenic acid induces mitochondrial dysfunction in lung cancer A549 cells by inhibiting the PI3K-Akt pathway[J]. Journal of International Oncology, 2024, 51(1): 21-28. |
[3] | Xiang Yuling, Tan Jiajie, Xiong Yuanguo, Zhao Lirong, Li Chen, Zhang Hong.Effects of Anhydroicaritin on the proliferation, migration and apoptosis of hepatocellular carcinoma cells[J]. Journal of International Oncology, 2023, 50(9): 513-519. |
[4] | Feng Dongxu, Wu Wei, Gao Pingfa, Wang Jun, Shi Lijuan, Chen Dawei, Li Wenbing, Zhang Meifeng.Effects of miR-451 on glycolysis and apoptosis of breast cancer cells by regulating Rho/ROCK1 pathway[J]. Journal of International Oncology, 2023, 50(8): 449-456. |
[5] | Wu Jiali, Zhang Jiahui, Zhang Ping, Xiao Xinyue, Li Rui, Zhang Hongyu.Mechanism of Bcl-2 BH4 selective inhibitor BDA-366 on NK/T cell lymphoma cells[J]. Journal of International Oncology, 2023, 50(7): 413-418. |
[6] | Zhu Yi, Chen Jian.Mechanism of hydrogen sulfide in tumorigenesis and development and its donor-mediated anti-tumor effects[J]. Journal of International Oncology, 2023, 50(12): 729-733. |
[7] | Lian Haiwei, Yang Shuorui, Liu Renzhong.Mechanism study on regulation of glioblastoma cell proliferation and apoptosis by sciadopitysin combined with CX-4945 through Notch1 pathway[J]. Journal of International Oncology, 2022, 49(6): 321-326. |
[8] | Yang Ya, Ning Xiaofei, Li Bingliang, Yao Hui, Shan Changping, Lyu Min.Study on the mechanism of procyanidin mediated anti gastric cancer SNU-1 cell line by inducing the production of reactive oxygen species[J]. Journal of International Oncology, 2022, 49(5): 257-262. |
[9] | Jing Wenjun, Zhao Wenwen, Feng Qingqing, Zhao Wenfei, Zhao Lili, Zhang Xue, Wei Hongmei.Molecular basis and clinical prospect of the miR-34 family for the treatment of gastric cancer[J]. Journal of International Oncology, 2022, 49(11): 681-686. |
[10] | Cai Jiahui, Rong Guanghong.Mechanism and clinical significance of YAP in the progression of gastric cancer[J]. Journal of International Oncology, 2022, 49(11): 687-691. |
[11] | Hu Guangyue, Yin Hong, Zhang Hui, Luo Hong.Efficacy predictors of immune checkpoint inhibitors in the treatment of metastatic gastric cancer[J]. Journal of International Oncology, 2021, 48(8): 498-501. |
[12] | Jiang Mengting, Wang Jiachun, Zong Jing.Effects of NFAT5 inhibition on proliferation, invasion, migration and apoptosis of lung adenocarcinoma cells[J]. Journal of International Oncology, 2021, 48(6): 321-327. |
[13] | Wang Xianwei, Shi Meiyan, Wang Fengqin, Qi Fu, Wang Chaozhe, Zhou Fei.Roles of TSA upregulation miR-4298 targeting inhibition of PADI4 expression in inducing U251 cells apoptosis[J]. Journal of International Oncology, 2021, 48(4): 193-199. |
[14] | Ma Xiuzhen, Lu Yan, Zhao Bingbing, Qiu Hongcong, Xu Xun, Wei Min.Effects of total flavonoids from Baeckea frutescens on the migration, invasion and apoptosis of cervical cancer SiHa cells[J]. Journal of International Oncology, 2021, 48(4): 206-211. |
[15] | Li Zhefeng, Li Jie, Zhao Xiaoting, Yue Wentao.GLDC regulates proliferation and apoptosis of ovarian cancer cells through PI3K/Akt/mTOR pathway[J]. Journal of International Oncology, 2021, 48(12): 716-722. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||